Stock Market

Investors remain puzzled due to persistent macro challenges, continued interest rate hikes, and the regional banking crisis. Given the ongoing uncertainties, sectors that are resilient during economic downturns could offer attractive investment opportunities. While not entirely immune to recessionary conditions, healthcare companies have the ability to navigate a tough macro backdrop due to the essential
0 Comments
Fintech is revolutionizing the banking sector. In fact, artificial intelligence (AI), and blockchain could lead to a far more efficient and accessible system. Fueling the boom, we’re already seeing a good deal of global cashless payments. According to PwC, global cashless payment volumes are expected to jump to more than 80% by 2025. Plus, according
0 Comments
At first glance, the first-quarter 2023 results from electric vehicle (EV) manufacturer Tesla (NASDAQ:TSLA) don’t seem all that bad. However, many investors’ initial reaction was to sell TSLA stock. In the wake of this, opinions vary concerning the future trajectory of the Tesla share price. Fortunately, there is a dip-buying strategy that could work well
0 Comments
Is Wall Street’s opinion of Plug Power (NASDAQ:PLUG) optimistic or pessimistic? There’s an odd divergence between the ambitious consensus price target on PLUG stock and the multitude of downgrades. Still, hopefully, today we can wade through the sea of opinions and come to a conclusion about Plug Power. Plug Power is probably the most famous publicly
0 Comments
Source: Robert Way / Shutterstock.com Nio (NYSE:NIO) is facing rapidly increasing competition. Meanwhile, the company’s margins are also being pressured by an accelerating price war in the Chinese electric vehicle (EV) market. But that’s not all. Nio’s addressable market is quite limited and the firm lacks strong competitive advantages. Given all of these points, I
0 Comments
Investors have shown keen interest in biotech after Johnson & Johnson’s (NYSE:JNJ) impressive earnings beat that topped Wall Street’s expectations. The earnings beat reignited enthusiasm for biotech stocks, prompting investors to search for the next big players. The pharmaceutical giant’s adjusted earnings and revenue beat expectations, with strength reported in units including pharmaceuticals. J&J also
0 Comments